The National Institutes of Health is running a Phase 1 clinical trial on an experimental mRNA universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center.
Although the vaccine is only in very early clinical trials, the U.K. government already has committed to a £1 billion deal with Moderna to buy the mRNA vaccines for flu and other respiratory viruses over the next 10 years, John Campbell, Ph.D., reported on his YouTube show.
“This really is quite bizarre in my view,” said Campbell, a retired nurse teacher in England who hosts a popular YouTube show that explains evolving science on COVID-19 and related issues.
“Why don’t we get the trial data first and then think about giving the thousand million pounds [£1 billion]” for the mass manufacture of the vaccines, he asked.
Poster Comment:
That is a kill shot for anyone who had covid vaxxes.